These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3209529)

  • 21. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transintestinal elimination of ciprofloxacin.
    Rohwedder R; Bergan T; Thorsteinsson SB; Scholl H
    Chemotherapy; 1990; 36(2):77-84. PubMed ID: 2311444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E; Portmann R; Partos C; Dell D
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees].
    Yu H; Wang HY; Sun ZM
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):449-51. PubMed ID: 7867438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
    Dan M; Poch F; Quassem C; Kitzes R
    Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of famotidine on ciprofloxacin pharmacokinetics after single intravenous and oral doses in rats.
    al-Khamis KI; Jim LK; Bawazir SA; Ashour LF; el-Sayed N; el-Sayed YM
    J Clin Pharm Ther; 1994 Dec; 19(6):335-9. PubMed ID: 7876363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group.
    Lipman J; Scribante J; Gous AG; Hon H; Tshukutsoane S
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2235-9. PubMed ID: 9736541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of enrofloxacin and ciprofloxacin in Atlantic horseshoe crabs (Limulus polyphemus) after single injection.
    Kirby A; Lewbart GA; Hancock-Ronemus A; Papich MG
    J Vet Pharmacol Ther; 2018 Apr; 41(2):349-353. PubMed ID: 29067728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.
    Hawkins MG; Taylor IT; Byrne BA; Armstrong RD; Tell LA
    J Vet Pharmacol Ther; 2011 Aug; 34(4):350-8. PubMed ID: 20950349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and toxicity of ciprofloxacin in adult horses.
    Yamarik TA; Wilson WD; Wiebe VJ; Pusterla N; Edman J; Papich MG
    J Vet Pharmacol Ther; 2010 Dec; 33(6):587-94. PubMed ID: 21062312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D; Tack K; Flor S
    Int J Clin Pharmacol Res; 1991; 11(5):203-9. PubMed ID: 1814841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
    Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics in the elderly. Studies on ciprofloxacin.
    Lebel M; Bergeron MG
    Am J Med; 1987 Apr; 82(4A):108-14. PubMed ID: 3555025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.